FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090804 [Registered on: 14/07/2025] Trial Registered Prospectively
Last Modified On: 12/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Evaluating the effectiveness of ropivacaine with dexamethasone for pain after wisdom tooth removal 
Scientific Title of Study   Evaluation of efficacy of Ropivacaine hydrochloride with Dexamethasone in third molar surgery 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  RUKMINI 
Designation  POST GRADUATE STUDENT 
Affiliation  Ragas Dental College and Hospital 
Address  Room number 2,Department of Oral and Maxillofacial Surgery Ragas Dental College and Hospital 2/102,EAST COAST ROAD,UTHANDI, Chennai-600119

Chennai
TAMIL NADU
600119
India 
Phone  9750374581  
Fax    
Email  srukmini493@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  B.VIKRAMAN 
Designation  HEAD OF THE DEPARTMENT 
Affiliation  Ragas Dental College and Hospital 
Address  Room number 2,Department of Oral and Maxillofacial Surgery Ragas Dental College and Hospital 2/102,EAST COAST ROAD,UTHANDI, Chennai-600119

Chennai
TAMIL NADU
600119
India 
Phone  9750374581  
Fax    
Email  vikramanvikraman@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr.B.Vikraman 
Designation  HEAD OF THE DEPARTMENT 
Affiliation  Ragas Dental College and Hospital 
Address  Room number 2,Department of Oral and Maxillofacial Surgery Ragas Dental College and Hospital 2/102,EAST COAST ROAD,UTHANDI, Chennai-600119

Chennai
TAMIL NADU
600119
India 
Phone  9840059597  
Fax    
Email  vikramanvikraman@gmail.com  
 
Source of Monetary or Material Support  
Room number 2,Department of Oral and Maxillofacial Surgery Ragas Dental College and Hospital2/102,EAST COAST ROAD,UTHANDI, Chennai-600119 
 
Primary Sponsor  
Name  RUKMINI 
Address  Room number 2,Department of Oral and Maxillofacial Surgery Ragas Dental College and Hospital 2/102,EAST COAST ROAD,UTHANDI, Chennai-600119 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrRUKMINI  RAGAS DENTAL COLLEGE AND HOSPITAL  Room number2,Department of Oral and Maxillofacial Surgery, 2/102,EAST COAST ROAD,UTHANDI, Chennai-600119
Chennai
TAMIL NADU 
9750374581

srukmini493@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethics Committee Ragas Dental College and Hospital Uthandi, Chennai -119 Tam  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  PATIENTS UNDERGOING BILATERAL WISDOM TOOTH REMOVAL 
Patients  (1) ICD-10 Condition: K011||Impacted teeth,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  0.75% ROPIVACAINE WITH 4mg DEXAMETHASONE   o.75% Ropivacaine with 4mg dexamethasone is given as inferior alveolar nerve block for wisdom tooth removal  
Comparator Agent  2% LIDOCAINE WITH 4mg DEXAMETHASONE  2% Lidocaine with 4mg Dexamethasone is given as inferior alveolar nerve block for wisdom tooth removal 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1)all patients who desire surgical extraction of non infected bilaterally impacted lower third molar
2)age group above 18 years
3)both sexes should be included
4)patients with no presenting acute systemic illness such as fever, common cold
5)patients who agree to enroll in the study
6)be available for follow up examinations
 
 
ExclusionCriteria 
Details  1)a history of systemic diseases that contraindicate surgical intervention
2)compromised health conditions,which would affect wound healing
3)acute infection in the surgical site
4)documented allergy to any materials utilised in the study
5)opting out of participating in the study
6)patient with a history of psychiatric disorder
7)pregnancy or lactation 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1)duration of soft tissue anesthesia
2)pain
3)swelling
4)mouth opening 
intra operatively, 
 
Secondary Outcome  
Outcome  TimePoints 
1)SWELLING
2)MOUTH OPENING
3)PAIN 
POSTOPERATIVE DAYS 3,5,7 
 
Target Sample Size   Total Sample Size="15"
Sample Size from India="15" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   11/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a spilt mouth study done in patients with bilaterally impacted mandibular third molars  by administrating 0.75% Ropivacine with 4mg Dexamtheasone and 2%Lidocaine with 4mg Dexamethasone to assess its efficacy for duration of soft tissue anesthesia, pain, swelling and mouth opening on postoperative days 3,5 and 7. 
Close